1. Home
  2. PAX vs KLRA Comparison

PAX vs KLRA Comparison

Compare PAX & KLRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Patria Investments Limited

PAX

Patria Investments Limited

HOLD

Current Price

$9.54

Market Cap

1.8B

Sector

Finance

ML Signal

HOLD

Logo Kailera Therapeutics Inc. Common Stock

KLRA

Kailera Therapeutics Inc. Common Stock

HOLD

Current Price

$12.25

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PAX
KLRA
Founded
1988
2024
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.7B
IPO Year
2020
2026

Fundamental Metrics

Financial Performance
Metric
PAX
KLRA
Price
$9.54
$12.25
Analyst Decision
Buy
Strong Buy
Analyst Count
6
6
Target Price
$14.83
★ $42.75
AVG Volume (30 Days)
★ 1.5M
1.1M
Earning Date
11-03-2026
11-04-2026
Dividend Yield
★ 6.66%
N/A
EPS Growth
N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$13.22
N/A
Revenue Next Year
$9.41
N/A
P/E Ratio
$25.65
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.03
$9.76
52 Week High
$17.80
$23.82

Technical Indicators

Market Signals
Indicator
PAX
KLRA
Relative Strength Index (RSI) 38.96 51.95
Support Level N/A $9.76
Resistance Level $11.74 $19.15
Average True Range (ATR) 0.40 0.79
MACD -0.21 0.13
Stochastic Oscillator 23.40 61.42

Price Performance

Historical Comparison
PAX
KLRA

About PAX Patria Investments Limited

Patria Investments Ltd is an alternative asset management firm specializing in resilient sectors across select regions. It seeks to provide world-wide and Latin American investors with attractive investment products that allows portfolio diversification and consistent returns. The group promotes inclusive and sustainable development in the Asset Classes: Private Equity, Private Equity Solutions, Credit, Real Estate, Infrastructure, and Public Equities Main sectors: Agribusiness, Power & Energy, Healthcare, Logistics & Transportations, Food & Beverage and Digital & Tech Services Investment Regions.

About KLRA Kailera Therapeutics Inc. Common Stock

Kailera Therapeutics Inc is a clinical-stage biotechnology company. The company focuses on developing a diversified pipeline to provide options for people living with obesity. The company is progressing four clinical-stage product candidates, leveraging multiple GLP-1 based mechanisms of action and routes of administration. The company's obesity-first approach seeks to advance product candidates with the potential to maximize weight loss and address critical needs in the current therapeutic landscape.

Share on Social Networks: